메뉴 건너뛰기
Practical Diabetes International
Volumn 22, Issue 4, 2005, Pages 115-116
NICE guidance on insulin pump therapy: Time for a re-appraisal?
Author keywords

[No Author keywords available]
Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE; ISOPHANE INSULIN;
EID: 20444476699     PISSN: 13578170     EISSN: None     Source Type: Journal    
DOI: 10.1002/pdi.774     Document Type: Article
Times cited : (6)
References (7)
  • 1
    • 20444499644 scopus 로고    scopus 로고
    • NICE Technology Appraisal Guidance No. 57: Guidance on the use of continuous subcutaneous insulin infusion for diabetes
    • National Institute for Clinical Excellence, February
    • NICE Technology Appraisal Guidance No. 57: Guidance on the use of continuous subcutaneous insulin infusion for diabetes. National Institute for Clinical Excellence, February 2003.
    • (2003)
  • 2
    • 7444266730 scopus 로고    scopus 로고
    • Continuous subcutaneous insulin infusion versus multiple daily injections: The impact of baseline HbA1c
    • Retnakaran R, Hochman J, De Vries JH, et al. Continuous subcutaneous insulin infusion versus multiple daily injections: The impact of baseline HbA1c. Diabetes Care 2004; 27: 2590-2596.
    • (2004) Diabetes Care , vol.27 , pp. 2590-2596
    • Retnakaran, R.1    Hochman, J.2    De Vries, J.H.3
  • 3
    • 3042838907 scopus 로고    scopus 로고
    • A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine
    • Doyle EA, Weinzimer SA, Steffen AT, et al. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004; 27: 1554-1558.
    • (2004) Diabetes Care , vol.27 , pp. 1554-1558
    • Doyle, E.A.1    Weinzimer, S.A.2    Steffen, A.T.3
  • 4
    • 17144391106 scopus 로고    scopus 로고
    • Optimization of basal insulin delivery in Type 1 diabetes: A retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine
    • Fahlén M, Eliasson B, Odén A. Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine. Diabetic Med 2005; 22: 382-386.
    • (2005) Diabetic Med. , vol.22 , pp. 382-386
    • Fahlén, M.1    Eliasson, B.2    Odén, A.3
  • 5
    • 14644418463 scopus 로고    scopus 로고
    • Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetes patients treated with CSII
    • Hirsch IB, Bode BW, Garg S, et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetes patients treated with CSII. Diabetes Care 2005; 28: 533-538.
    • (2005) Diabetes Care , vol.28 , pp. 533-538
    • Hirsch, I.B.1    Bode, B.W.2    Garg, S.3
  • 6
    • 18644364317 scopus 로고    scopus 로고
    • Effectiveness of continuous subcutaneous insulin infusion in hypoglycaemia-prone type 1 diabetes. Implications for NICE guidelines
    • Pickup JC, Kidd J, Burmiston S, et al. Effectiveness of continuous subcutaneous insulin infusion in hypoglycaemia-prone type 1 diabetes. Implications for NICE guidelines. Pract Diabetes Int 2005; 22: 10-16.
    • (2005) Pract. Diabetes Int. , vol.22 , pp. 10-16
    • Pickup, J.C.1    Kidd, J.2    Burmiston, S.3
  • 7
    • 13244292294 scopus 로고    scopus 로고
    • Insulin pump therapy in children and adolescents: Improvements in key parameters of diabetes management including quality of life
    • McMahon SK, Airey FL, Marangou DA, et al. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabetic Med 2005; 22: 92-96.
    • (2005) Diabetic Med. , vol.22 , pp. 92-96
    • McMahon, S.K.1    Airey, F.L.2    Marangou, D.A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.